Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 22 Mar 2021

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

in Thoracic Oncology

Federica Pezzuto
Francesca Lunardi
Luca Vedovelli
Francesco Fortarezza
Loredana Urso
Federica Grosso
Giovanni Luca Ceresoli
Izidor Kern
Gregor Vlacic
Eleonora Faccioli

Frontiers in Oncology

doi 10.3389/fonc.2021.653497

4,906 views
14 citations

Original Research

Published on 22 Mar 2021

Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database

in Thoracic Oncology

Jung Soo Lee
Seoree Kim
Soo-Yoon Sung
Yeo Hyung Kim
Hyun Woo Lee
Ji Hyung Hong
Yoon Ho Ko

Frontiers in Oncology

doi 10.3389/fonc.2021.546672

5,224 views
7 citations

Original Research

Published on 22 Mar 2021

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer

in Thoracic Oncology

Xinyu Zhang
Chun Li
Maosong Ye
Qin Hu
Jie Hu
Ziying Gong
Jieyi Li
Xiaokai Zhao
Yiqing Xu
Daoyun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.602402

5,357 views
10 citations

Original Research

Published on 22 Mar 2021

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

in Thoracic Oncology

Liang Shi
Junfang Tang
Hong Tao
Lili Guo
Weihua Wu
Hongbo Wu
Zichen Liu
Li Tong
Wei Wu
Hongxia Li

Frontiers in Oncology

doi 10.3389/fonc.2021.622142

4,322 views
12 citations

Case Report

Published on 18 Mar 2021

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma

in Thoracic Oncology

Zhongben Tang
Feng Lin
Jiarong Xiao
Xiaojun Du
Jian Zhang
Sini Li
Gongshun Tang
Chen Chen
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2021.605658

3,142 views
6 citations

Original Research

Published on 16 Mar 2021

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Juan Zhou
Jing Zhao
Qingzhu Jia
Qian Chu
Fei Zhou
Xiangling Chu
Wencheng Zhao
Shengxiang Ren
Caicun Zhou
Chunxia Su

Frontiers in Oncology

doi 10.3389/fonc.2021.625578

6,018 views
25 citations

Original Research

Published on 15 Mar 2021

Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study

in Thoracic Oncology

Peiliang Wang
Xiaozhuang Fang
Tianwen Yin
Hairong Tian
Jinming Yu
Feifei Teng

Frontiers in Oncology

doi 10.3389/fonc.2021.628124

12,992 views
74 citations

Original Research

Published on 15 Mar 2021

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers

in Thoracic Oncology

Atsuto Mouri
Kyoichi Kaira
Ou Yamaguchi
Kosuke Hashimoto
Yu Miura
Ayako Shiono
Shun Shinomiya
Tomoe Akagami
Hisao Imai
Kunihiko Kobayashi

Frontiers in Oncology

doi 10.3389/fonc.2021.610952

4,307 views
13 citations

Original Research

Published on 11 Mar 2021

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

in Thoracic Oncology

Sangtian Liu
Fengying Wu
Xuefei Li
Chao Zhao
Yijun Jia
Keyi Jia
Ruoshuang Han
Meng Qiao
Wei Li
Jia Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.639947

12,725 views
36 citations

Original Research

Published on 11 Mar 2021

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

in Thoracic Oncology

Maosong Ye
Xiaoxuan Zheng
Xin Ye
Juncheng Zhang
Chuoji Huang
Zilong Liu
Meng Huang
Xianjun Fan
Yanci Chen
Botao Xiao

Frontiers in Oncology

doi 10.3389/fonc.2021.638223

4,558 views
17 citations

Original Research

Published on 11 Mar 2021

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer

in Thoracic Oncology

Sarah-Louise Ryan
Keyur A. Dave
Sam Beard
Martina Gyimesi
Matthew McTaggart
Katherine B. Sahin
Christopher Molloy
Neha S. Gandhi
Eric Boittier
Connor G. O’Leary

Frontiers in Oncology

doi 10.3389/fonc.2021.615967

6,537 views
8 citations

Original Research

Published on 10 Mar 2021

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors

in Thoracic Oncology

Elizabeth Dudnik
Jair Bar
Assaf Moore
Teodor Gottfried
Mor Moskovitz
Julia Dudnik
Tzippy Shochat
Aaron M. Allen
Alona Zer
Ofer Rotem

Frontiers in Oncology

doi 10.3389/fonc.2021.603223

7,390 views
17 citations

Original Research

Published on 10 Mar 2021

Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China

in Thoracic Oncology

Weize Lv
Hua Cheng
Di Shao
Yajun Wei
Weiping Zhu
Kui Wu
Wenxi Jiang
Liyang Hu
Zhou Sha
Beilong Zhong

Frontiers in Oncology

doi 10.3389/fonc.2021.630717

6,478 views
10 citations

Original Research

Published on 09 Mar 2021

Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD

in Thoracic Oncology

Ti-wei Miao
Long-yi Du
Wei Xiao
Bing Mao
Yan Wang
Juan-juan Fu

Frontiers in Oncology

doi 10.3389/fonc.2021.600243

5,546 views
14 citations

Original Research

Published on 09 Mar 2021

Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer—A Clinicopathological Series

in Thoracic Oncology

Marclesson Alves
Daniela de Paula Borges
Aline Kimberly
Francisco Martins Neto
Ana Claudia Oliveira
Juliana Cordeiro de Sousa
Cleto D. Nogueira
Benedito A. Carneiro
Fabio Tavora

Frontiers in Oncology

doi 10.3389/fonc.2021.621050

8,289 views
17 citations

Original Research

Published on 08 Mar 2021

Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib

in Thoracic Oncology

Hui Zheng
Qin Pan
Wenchao Zhu
Hongsen Li
Zhongfeng Niu
Yong Fang
Da Li
Haizhou Lou
Hong Hu
Jiawei Shou

Frontiers in Oncology

doi 10.3389/fonc.2021.628693

3,522 views
3 citations

Original Research

Published on 05 Mar 2021

Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China

in Thoracic Oncology

Xiaoling Chen
Jun Nie
Ling Dai
Weiheng Hu
Jie Zhang
Jindi Han
Xiangjuan Ma
Guangming Tian
Sen Han
Di Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.607531

6,469 views
31 citations

Original Research

Published on 05 Mar 2021

Classification of Metastatic and Non-Metastatic Thoracic Lymph Nodes in Lung Cancer Patients Based on Dielectric Properties Using Adaptive Probabilistic Neural Networks

in Thoracic Oncology

Di Lu
Hongfeng Yu
Zhizhi Wang
Zhiming Chen
Jiayang Fan
Xiguang Liu
Jianxue Zhai
Hua Wu
Xuefei Yu
Kaican Cai

Frontiers in Oncology

doi 10.3389/fonc.2021.640804

3,353 views
9 citations

Editorial

Published on 05 Mar 2021

Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment

in Thoracic Oncology

Alex Molassiotis
Patsy Yates
Janelle Yorke

Frontiers in Oncology

doi 10.3389/fonc.2021.651797

4,957 views
5 citations

Original Research

Published on 05 Mar 2021

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses

in Thoracic Oncology

Donglai Chen
Yifei Wang
Xi Zhang
Qifeng Ding
Xiaofan Wang
Yuhang Xue
Wei Wang
Yiming Mao
Chang Chen
Yongbing Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.581030

5,783 views
14 citations

Original Research

Published on 05 Mar 2021

Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis

in Thoracic Oncology

Lingxiao Qiu
Pan Song
Pingmei Chen
Huaqi Wang
Fangfang Li
Mengxuan Shu
Gen-cheng Gong
Xiangjin Song
Chun Huang
Hongxia Jia

Frontiers in Oncology

doi 10.3389/fonc.2021.601185

5,779 views
18 citations

Original Research

Published on 04 Mar 2021

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism

in Thoracic Oncology

Huikang Xie
Hang Su
Erjia Zhu
Chang Gu
Shengnan Zhao
Yunlang She
Yijiu Ren
Dong Xie
Hui Zheng
Chunyan Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.608353

6,739 views
33 citations

Original Research

Published on 03 Mar 2021

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer

in Thoracic Oncology

Yang Hong
Jiahui Si
Jie Zhang
Ying Xiong
Jianzhi Zhang
Peter Ping Lin
Jian Fang
Yue Yang
Chao Lv
Yuanyuan Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.590952

2,832 views
8 citations

Original Research

Published on 03 Mar 2021

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer

in Thoracic Oncology

Dan Su
Gao Wu
Ran Xiong
Xiangxiang Sun
Meiqing Xu
Yide Mei
Xianning Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.634059

7,591 views
20 citations

1,976 articles

articles

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors

Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China

Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD

Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer—A Clinicopathological Series

Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib

Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China

Classification of Metastatic and Non-Metastatic Thoracic Lymph Nodes in Lung Cancer Patients Based on Dielectric Properties Using Adaptive Probabilistic Neural Networks

Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses

Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer